Cervicofacial non-tuberculous mycobacteria: A report of 30 cases

Wolinsky, 1995, Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up, Clin Infect Dis, 20, 954, 10.1093/clinids/20.4.954 Lu, 2002, Comparison of the Automated Mycobacteria Growth Indicator Tube System (BACTEC 960/MGIT) with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens, Am J Clin Pathol, 118, 542, 10.1309/65KN-2M7E-7MNN-X0TA Lai, 1984, Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age, JAMA, 251, 1286, 10.1001/jama.1984.03340340026019 Panesar, 2003, Nontuberculous mycobacterial cervical adenitis: a ten-year retrospective review, Laryngoscope, 113, 149, 10.1097/00005537-200301000-00028 Lima, 2013, Rapid detection and differentiation of mycobacterial species using a multiplex PCR system, Rev Soc Bras Med Trop, 46, 447, 10.1590/0037-8682-0097-2013 Timmerman, 2008, Treatment of non-tuberculous mycobacterial cervicofacial lymphadenitis in children: critical appraisal of the literature, Clin Otolaryngol, 33, 546, 10.1111/j.1749-4486.2008.01821.x Wei, 2008, Treatment outcomes for nontuberculous mycobacterial cervicofacial lymphadenitis in children based on the type of surgical intervention, Otolaryngol Head Neck Surg, 138, 566, 10.1016/j.otohns.2008.01.022 Tunkel, 1999, Surgery for cervicofacial nontuberculous mycobacterial adenitis in children: an update, Arch Otolaryngol Head Neck Surg, 125, 1109, 10.1001/archotol.125.10.1109 Lindeboom, 2007, Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial, Clin Infect Dis, 44, 1057, 10.1086/512675 Lindeboom, 1999, Clarithromycin as a single-modality treatment in mycobacterial avium-intracellular infections, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 87, 50, 10.1016/S1079-2104(99)70294-5 Green, 1993, Mycobacterium avium complex parotid lymphadenitis: successful therapy with clarithromycin and ethambutol, Pediatr Infect Dis J, 12, 615, 10.1097/00006454-199307000-00015 Tessier, 1994, Clarithromycin for atypical mycobacterial lymphadenitis in non-immunocompromised children, Lancet, 344, 1778, 10.1016/S0140-6736(94)92920-3 Henry, 2004, Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response, Eur Respir J, 23, 741, 10.1183/09031936.04.00114004 Lindeboom, 2011, Conservative wait-and-see therapy versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children, Clin Infect Dis, 52, 180, 10.1093/cid/ciq070 Lévy-Bruhl D. Inserm. Politiques vaccinales et impact épidémiologique de la vaccination. Rev Epidemiol Sante Publique 2005;53(5):501–8. http://www.ipubli.inserm.fr/bitstream/handle/10608/151/?sequence=16. Romanus, 1995, Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage, Tuber Lung Dis, 76, 300, 10.1016/S0962-8479(05)80028-0